Clinical Trial Update: First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 trial of OnKure's OKI-219 is currently recruiting for advanced solid tumors and breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• OKI-219 (OKI-219)

Snippet

Sponsor: OnKure, Inc. | Conditions: Advanced Cancer, Breast Cancer | Phase 1 | Status: RECRUITING